These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36326326)

  • 41. The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia.
    Ichinose M; Fujimoto A; Osuga Y; Minaguchi T; Kawana K; Yano T; Kozuma S
    Int J Gynecol Cancer; 2013 Feb; 23(2):288-93. PubMed ID: 23314282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stromal p16 expression is significantly increased in endometrial carcinoma.
    Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
    Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma.
    Yildirim HT; Nergiz D; Sadullahoglu C; Akgunduz Z; Yildirim S; Dogan S; Sezer C
    Indian J Pathol Microbiol; 2020; 63(3):412-417. PubMed ID: 32769330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.
    Uccella S; Zorzato PC; Dababou S; Bosco M; Torella M; Braga A; Frigerio M; Gardella B; Cianci S; Laganà AS; Franchi MP; Garzon S
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
    Acta Obstet Gynecol Scand; 2019 Aug; 98(8):976-987. PubMed ID: 30779338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms.
    Clarke MA; Long BJ; Sherman ME; Lemens MA; Podratz KC; Hopkins MR; Ahlberg LJ; Mc Guire LJ; Laughlin-Tommaso SK; Bakkum-Gamez JN; Wentzensen N
    Am J Obstet Gynecol; 2020 Oct; 223(4):549.e1-549.e13. PubMed ID: 32268124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.
    Fan Y; Li X; Wang J; Wang Y; Tian L; Wang J
    Reprod Biol Endocrinol; 2021 Aug; 19(1):118. PubMed ID: 34344384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can preoperative inflammatory markers differentiate endometrial cancer from complex atypical hyperplasia/endometrial intraepithelial neoplasia?
    Selen S; Kilic F; Kimyon Comert G; Unsal M; Kilic C; Karalok A; Turkmen O; Turan T
    J Obstet Gynaecol Res; 2020 Jul; 46(7):1148-1156. PubMed ID: 32464701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment.
    Yang YF; Liao YY; Liu XL; Su SG; Li LZ; Peng NF
    Gynecol Oncol; 2015 Dec; 139(3):419-23. PubMed ID: 26494424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fertility-Sparing Management Using Progestin for Young Women with Endometrial Cancer From a Population-Based Study.
    Kim SR; van der Zanden C; Ikiz H; Kuzelijevic B; Havelock J; Kwon JS
    J Obstet Gynaecol Can; 2018 Mar; 40(3):328-333. PubMed ID: 28986185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Membrane expression of the death ligand trail receptors DR4 and DR5 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer.
    Gottwald L; Szwalski J; Piekarski J; Pasz-Walczak G; Kubiak R; Spych M; Suzin J; Tyliński W; Sęk P; Jeziorski A
    J Obstet Gynaecol; 2013 Jul; 33(5):512-8. PubMed ID: 23815209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endometrial hyperplasia as a risk factor of endometrial cancer.
    Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
    Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
    Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?
    Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W
    Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Corrado G; Baiocco E; Carosi M; Vizza E
    Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Focal adhesion kinase overexpression in endometrial neoplasia.
    Livasy CA; Moore D; Cance WG; Lininger RA
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):342-5. PubMed ID: 15536334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al in Annals of Diagnostic Pathology 2007;11:297-311.
    Zheng W; Chambers SK
    Ann Diagn Pathol; 2008 Jun; 12(3):231-2; author reply 232-3. PubMed ID: 18486902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.